Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients
Mar 04, 2013•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.
For the best experience, listen in Metacast app for iOS or Android